BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2019 - 2026)

BioXcel Therapeutics' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 2.77 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio fell 9.36% year-over-year to 2.77; the TTM figure through Mar 2026 stood at 3.1 (up 11.29% YoY), while the FY2025 annual figure was 2.97, up 35.22% from the prior year.
• Interest Coverage Ratio was 2.77 for Q1 2026 at BioXcel Therapeutics, down from 2.34 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 2.34 in Q4 2025 to a low of 4497.14 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 273.16 across 5 years, with a median of 6.35 in 2023.
• The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio soared 99.65% in 2022, then tumbled 50.07% in 2023.
• A 5-year view of Interest Coverage Ratio shows it stood at 15.3 in 2022, then soared by 58.46% to 6.35 in 2023, then jumped by 56.66% to 2.75 in 2024, then grew by 15.07% to 2.34 in 2025, then slipped by 18.26% to 2.77 in 2026.
• The last three Interest Coverage Ratio figures came in at 2.77 (Q1 2026), 2.34 (Q4 2025), and 3.25 (Q3 2025), per Business Quant data.